Ontrak, Inc. (OTRK): Price and Financial Metrics
GET POWR RATINGS... FREE!
OTRK Stock Summary
- With a year-over-year growth in debt of -78.01%, ONTRAK INC's debt growth rate surpasses merely 2.27% of about US stocks.
- Revenue growth over the past 12 months for ONTRAK INC comes in at -78.33%, a number that bests merely 2.03% of the US stocks we're tracking.
- ONTRAK INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 254.4%, greater than the shareholder yield of 98.88% of stocks in our set.
- Stocks that are quantitatively similar to OTRK, based on their financial statements, market capitalization, and price volatility, are FUBO, CSTL, EOSE, VBIV, and UCL.
- OTRK's SEC filings can be seen here. And to visit ONTRAK INC's official web site, go to catasys.com.
OTRK Valuation Summary
- OTRK's EV/EBIT ratio is -0.2; this is 103.03% lower than that of the median Healthcare stock.
- OTRK's price/earnings ratio has moved NA NA over the prior 235 months.
Below are key valuation metrics over time for OTRK.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
OTRK | 2023-03-24 | 0.6 | 1.0 | -0.2 | -0.2 |
OTRK | 2023-03-23 | 0.6 | 1.0 | -0.2 | -0.2 |
OTRK | 2023-03-22 | 0.6 | 1.0 | -0.2 | -0.2 |
OTRK | 2023-03-21 | 0.6 | 1.1 | -0.2 | -0.2 |
OTRK | 2023-03-20 | 0.6 | 1.0 | -0.2 | -0.2 |
OTRK | 2023-03-17 | 0.5 | 0.8 | -0.2 | -0.2 |
OTRK Growth Metrics
- Its year over year cash and equivalents growth rate is now at -68.77%.
- Its 5 year cash and equivalents growth rate is now at 4024.05%.
- Its 5 year net cashflow from operations growth rate is now at -194.37%.

The table below shows OTRK's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 22.336 | -37.564 | -71.472 |
2022-06-30 | 38.087 | -43.524 | -66.591 |
2022-03-31 | 60.669 | -43.078 | -55.25 |
2021-12-31 | 84.133 | -26.155 | -46.098 |
2021-09-30 | 103.052 | -11.309 | -28.561 |
2021-06-30 | 108.48 | 0.422 | -24.576 |
OTRK's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- OTRK has a Quality Grade of C, ranking ahead of 27.92% of graded US stocks.
- OTRK's asset turnover comes in at 0.857 -- ranking 29th of 81 Healthcare stocks.
- GENN, DGX, and SSY are the stocks whose asset turnover ratios are most correlated with OTRK.
The table below shows OTRK's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.857 | 0.560 | -0.232 |
2021-03-31 | 0.997 | 0.505 | -0.317 |
2020-12-31 | 1.201 | 0.474 | -0.398 |
2020-09-30 | 1.686 | 0.433 | -0.604 |
2020-06-30 | 2.085 | 0.400 | -0.818 |
2020-03-31 | 1.862 | 0.394 | -0.960 |
OTRK Price Target
For more insight on analysts targets of OTRK, see our OTRK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $22.00 | Average Broker Recommendation | 1.9 (Hold) |
OTRK Stock Price Chart Interactive Chart >
OTRK Price/Volume Stats
Current price | $0.49 | 52-week high | $2.53 |
Prev. close | $0.50 | 52-week low | $0.34 |
Day low | $0.49 | Volume | 54,554 |
Day high | $0.52 | Avg. volume | 4,077,030 |
50-day MA | $0.75 | Dividend yield | N/A |
200-day MA | $0.67 | Market Cap | 13.37M |
Ontrak, Inc. (OTRK) Company Bio
Ontrak, Inc. operates as a health care technology company. The Company develops platform to improve behavioral health conditions that cause and exacerbate chronic medical diseases such as diabetes, hypertension, coronary artery, and congestive heart failure. Ontrak serves customers in the United States.
Latest OTRK News From Around the Web
Below are the latest news stories about ONTRAK INC that investors may wish to consider to help them evaluate OTRK as an investment opportunity.
Ontrak Health Will Bring MyndYou’s AI-Powered, Active Listening Virtual Care Assistant to Its Behavioral Health MembersHENDERSON, Nev. & NEW YORK, March 28, 2023--Ontrak, Inc. (NASDAQ: OTRK), a leading AI-powered and telehealth-enabled health care company, and MyndYou, creators of an AI-powered Virtual Care Coordinator, today jointly announced that Ontrak Health will use MyndYou's MyEleanor, an AI-powered conversational platform, to engage with members, triage needs, and address issues pertaining to behavioral, medical, or social care needs. |
Ontrak Announces 2022 Fourth Quarter and Year End Financial ResultsHENDERSON, Nev., March 15, 2023--Ontrak, Inc. (NASDAQ: OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today reported its financial results for the fourth quarter and year ended December 31, 2022. |
Ontrak Health Partners with Lyssn.io to Strengthen Coaching OutcomesHENDERSON, Nev., March 09, 2023--Ontrak Health (NASDAQ: OTRK), a leading AI-powered and telehealth-enabled healthcare company, announced a partnership with Lyssn, an innovative software platform that uses AI and natural language processing to enhance communication and outcomes between healthcare professionals and their members. The partnership will provide Ontrak Health Care Coaches with real-time analysis and feedback on the fidelity of Motivational Interviewing (MI) during coaching calls with |
MULN Stock Alert: SEC Charges Mullen Financier With Insider TradingThe SEC has charged Mullen financier Acuitas Group, and its CEO, Terren Peizer with insider trading on material, nonpublic information. |
Healthcare CEO Faces Charges of Making Illicit Stock Sales in Prearranged TradesThe founder of telehealth provider Ontrak was charged in a first-of-its-kind criminal insider-trading case, with prosecutors alleging he sold millions of dollars worth of stock while misusing a trading plan that executives normally deploy to shield themselves from such suspicions. Ontrak Chief Executive Terren Peizer set up the prearranged trading plans in May and August 2021, just before his company disclosed the loss of health insurer Cigna as a major customer, according to a federal grand-jury indictment unsealed Wednesday. Mr. Peizer sold about 641,000 shares of Ontrak stock when he was aware of the undisclosed bad news, according to the Securities and Exchange Commission, which also sued him. |
OTRK Price Returns
1-mo | -21.10% |
3-mo | 33.30% |
6-mo | 4.26% |
1-year | -78.22% |
3-year | -96.78% |
5-year | -89.79% |
YTD | 33.30% |
2022 | -94.16% |
2021 | -89.82% |
2020 | 278.85% |
2019 | 74.07% |
2018 | 149.87% |
Loading social stream, please wait...